Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

Completed · Phase 3 · Has a placebo group

Conditions studied: Subjective Tinnitus

In brief

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.

Key facts

Study ID
NCT00955799
Run by
Merz Pharmaceuticals GmbH
People needed
455
Starts
2009-09-01
Expected to finish
2011-06-01
Last updated by the study team
2012-11-28

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.